Integration of a short Epstein—Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein—Barr nuclear antigens EBNA2 and EBNA5

References

1. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams A, Ziegler A. 1987; Production of a monoclonal antibodies to group A erythrocytes. HLA and other human cell surface antigens: new tools for genetic analysis.. Cell 14:9–20
   [Google Scholar]
2. Clark EA, Ledbetter IA, Holly RC, Dinndorf PA, Shu G. 1986; Polypeptides on human B-lymphocytes associated with cell activation.. Human Immunology 16:100–113
   [Google Scholar]
3. Colombani J, Dausett J, Lepage V, Degof L, Kalil J, Fellous M. 1982; HLA monoclonal registry; a proposal.. Tissue Antigens 20:161–171
   [Google Scholar]
4. Dambaugh T, Wang F, Hennesy K, Woodland E, Rickinson A, Kieff E. 1986; Expression of the Epstein–Barr virus nuclear antigen 2 in rodent cells.. Journal of Virology 59:453–162
   [Google Scholar]
5. Fahraeus R, Rymo L, Rhim JS, Klein G. 1990; Morphological transformation of human keratinocytes expressing the LMP gene of Epstein–Barr virus.. Nature, London 345:447–149
   [Google Scholar]
6. Finke J, Rowe M, Kallin B, Ernberg I, Rosen A, Dillner J, Klein G. 1987; Monoclonal and polyclonal antibodies against Epstein–Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt’s lymphoma and lymphoblastoid cell lines.. Journal of Virology 61:3870–3878
   [Google Scholar]
7. Gardella TP, Medveczky P, Sairenji T, Mulder C. 1984; Detection of circular and linear herpes virus DNA molecules in mammalian cells by gel electrophoresis.. Journal of Virology 50:248–254
   [Google Scholar]
8. Gualandi G, Santolini E, Calef E. 1992; Epstein–Barr virus DNA recombines via latent origin of replication with the human genome in the lymphoblastoid cell line, RGN1.. Journal of Virology 66:5677–5681
   [Google Scholar]
9. Hinuma Y, Grace JT. 1967; Cloning of immunoglobulin producing human leukemic and lymphoma cells in long term cultures.. Proceedings of the Society for Experimental Biology and Medicine 124:107–111
   [Google Scholar]
10. Hurley E, Thorley-Lawson D. 1988; Cell activation and the establishment of Epstein–Barr virus latency.. Journal of Experimental Medicine 168:2059–2075
    [Google Scholar]
11. Hurley E, Agger S, McNeil JA, Lawrence JB, Calendar A, Lenoir G, Thorley-Lawson D. 1991a; When Epstein–Barr virus persistently infects B-cell lines, it frequently integrates.. Journal of Virology 65:1245–1254
    [Google Scholar]
12. Hurley EA, Klaman L, Agger S, Lawrence JB, Thorley-Lawson D. 1991b; The prototypical Epstein–Barr virus transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA.. Journal of Virology 65:3958–3963
    [Google Scholar]
13. Jones MD, Foster L, Sheedy T, Griffin B. 1984; The EB virus genome in Daudi Burkitt lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR1) of the virus.. EMBO Journal 3:813–821
    [Google Scholar]
14. Kieff E, Liebowitz D. 1989; The Epstein–Barr virus.. Virology 21889–1920Edited by Fields BN, Knipe DM. New York: Raven Press.;
    [Google Scholar]
15. Klein G, Henriksson-Ehlin B, Schlossmann S. F. 1983; Induction of an activated B-lymphocyte associated surface moiety defined by the B2 monoclonal antibody by EBV conversion of an EBV negative lymphoma line (Ramos): differential effect of transforming (B95-8) and non-transforming (P3HR1) substrains.. Journal of Immunology 130:1985–1989
    [Google Scholar]
16. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4.. Nature, London 227:680–685
    [Google Scholar]
17. Lenoir G, Vuillaume M, Bonnardel C. 1985; The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt’s lymphoma.. In Burkitt’s Lymphoma: A Human Cancer Mode pp 309–318Edited by Lenoir G, Connor GO, Olweny CLM. Lyon: IARC.;
    [Google Scholar]
18. Lindahl T, Klein G, Reedman BM, Johansson B, Singh S. 1974; Relationship between Epstein–Barr virus DNA and EBV determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.. International Journal of Cancer 13:764–772
    [Google Scholar]
19. Maniatis T, Fritsch EF, Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory.;
    [Google Scholar]
20. Mann KP, Staunton D, Thorley-Lawson DA. 1985; Epstein–Barr virus-encoded protein found in plasma membranes of transformed cells.. Journal of Virology 55:710–720
    [Google Scholar]
21. Mannick J, Cohen J, Birkenbach M, Marchini A, Kieff E. 1991; The Epstein–Barr virus nuclear protein encoded by the leader of EBNA RNAs is important in B-lymphocyte transformation.. Journal of Virology 65:6826–6837
    [Google Scholar]
22. Patarroyo M, Prieto J, Ernberg I, Gahmberg CG. 1988; Absence or low expression, of leukocyte adhesion molecules CD 11 and CD 18 on Burkitt’s lymphoma cells.. International Journal of Cancer 41:901–907
    [Google Scholar]
23. Reedman BM, Klein G. 1973; Cellular localization of an Epstein–Barr virus (EBV)-associated complement fixing antigen in producer and non-producer lymphoblastoid cell lines.. International Journal of Cancer 11:499–520
    [Google Scholar]
24. Ritz J, Pesando JM, Notis-McConarty J, Lazarus H, Schlossman SF. 1980; A monoclonal antibody to human acute lymphoblastic leukaemia antigen.. London 283:583–585
    [Google Scholar]
25. Rowe M, Hilgreth JEK, Rickinson AB, Epstein MA. 1982; Monoclonal antibodies to Epstein–Barr virus-induced transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity.. International Journal of Cancer 29:373–381
    [Google Scholar]
26. Rowe M, Rowe DT, Gregory C, Young LS, Farrell PJ, Rupani H, Rickinson AB. 1987; Differences in B-cell growth phenotype reflect a novel pattern of Epstein–Barr virus latent gene expression in Burkitt’s lymphoma cells.. EMBO Journal 6:2743–2752
    [Google Scholar]
27. Torsteindottir S, Andersson ML, Avila-Carino J, Henriksson-Ehlin B, Masucci MG, Klein G, Klein E. 1989; Reversion of tumorigenicity and decreased agarose clon-ability after EBV conversion of an IgH/myc translocation carrying BL line.. International Journal of Cancer 43:273–278
    [Google Scholar]
28. Towbin H, Staehelin T, Gordon J. 1976; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.. Proceedings of the National Academy of Sciences, U.S.A. 76:4350–4354
    [Google Scholar]
29. Wang D, Leibowitz D, Kieff E. 1985; An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.. Cell 434:831–840
    [Google Scholar]
30. Weils J, Fellous M, Tursz T. 1981; Monoclonal antibody against a Burkitt lymphoma associated antigen.. Proceedings of the National Academy of Sciences, U.S.A. 78:6485–6488
    [Google Scholar]
31. Yates J, Warren N, Reisman D, Sugden B. 1984; A cis-acting element from the Epstein–Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.. Proceedings of the National Academy of Sciences, U.S.A. 81:3806–3810
    [Google Scholar]
32. Young LS, Alfieri C, Hennesy K, Evans H, O’Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen JI. 1989; Expression of Epstein–Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.. New England Journal of Medicine 321:1080–1085
    [Google Scholar]
33. Zimber-Strobl U, Suentzenich KO, Laux G, Eick D, Cordier M, Calender A, Billaud M, Lenoir G, Bornkamm GW. 1991; Epstein–Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.. Journal of Virology 65:415–423
    [Google Scholar]